Sort
16,300 grants matching “fatty liver disease”
Regulation of Hepatic Lipid Accumulation and Insulin Resistance
$357,750Jun Liu · Mayo Clinic Rochester · R01 · FY2019 · DK
Pathobiology of Liver Injury
$357,750Harmeet Malhi · Mayo Clinic Rochester · R01 · FY2019 · DK
Exploration of the functions of the ciliopathy Arls in cilia
$357,750Jinghua Hu · Mayo Clinic Rochester · R01 · FY2017 · DK
TGF beta Receptors and Cell Proliferation
$357,750Edward B Leof · Mayo Clinic Rochester · R01 · FY2016 · GM
Comprehensive noninvasive assessment of liver histopathology in nonalcoholic fatty liver disease (NAFLD) via magnetic resonance imaging, cytometry and elastography (MR-ICE)
$357,750Meng Yin · Mayo Clinic Rochester · R01 · FY2022 · EB
Comprehensive noninvasive assessment of liver histopathology in nonalcoholic fatty liver disease (NAFLD) via magnetic resonance imaging, cytometry and elastography (MR-ICE)
$357,750Meng Yin · Mayo Clinic Rochester · R01 · FY2023 · EB
Advanced Assessment of Hepatic Inflammation and Fibrosis with MR Elastography
$357,750Meng Yin · Mayo Clinic Rochester · R01 · FY2020 · EB
Pathobiology of Liver Injury
$357,750Harmeet Malhi · Mayo Clinic Rochester · R01 · FY2020 · DK
Advanced Assessment of Hepatic Inflammation and Fibrosis with MR Elastography
$357,750Meng Yin · Mayo Clinic Rochester · R01 · FY2016 · EB
Lipotoxicity and Liver Inflammation
$357,750Samar Ibrahim · Mayo Clinic Rochester · R01 · FY2022 · DK
Molecular Biophysics of Mitochondrial Membranes
$357,691Yuriy Kirichok · University Of California, San Francisco · R35 · FY2020 · GM
Immune regulation of adipose tissue mass
$357,561Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2017 · DK
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
$357,546Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2010 · DK
Liver Sinusoidal Endothelial Cell Progenitor Cells.
$357,516Laurie D Deleve · University Of Southern California · R01 · FY2014 · DK
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
$357,500Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2025 · DK
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
$357,500Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2023 · DK
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
$357,500Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2022 · DK
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
$357,445Vishwa Deep Dixit · Yale University · R01 · FY2021 · AR
Stress Signaling Pathways in Toxicity and Disease
$357,439Michael Karin · University Of California, San Diego · R01 · FY2007 · ES
Project 2: Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure
$357,318Ronald M. Evans · University Of California, San Diego · P42 · FY2020 · ES
Adipose Tissue Macrophage Phenotype and Function
$357,300Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2009 · DK
PPARa and related nuclear receptors in non-alcoholic fatty liver disease
$357,225Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2021 · DK
Prenatally induced DNA methylation profiles and disease risk at age 60
$357,184L H Lumey · Columbia University Health Sciences · R01 · FY2012 · AG
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
$357,156John P Thyfault · University Of Missouri-Columbia · R01 · FY2011 · DK
Augmentation of Trabecular Bone by Low Magnitude Strain
$357,117Clinton T Rubin · State University New York Stony Brook · R01 · FY2008 · AR